Postoperative Delirium Clinical Trial
Official title:
"Blue" Cerebrovascular Reactivity (CVR) Maps as a Marker for Post-operative Delirium (POD) in Patients Undergoing Abdominal Aortic Aneurysm (AAA) Surgery: A Pilot Study: Addition of Other Patients Being Admitted to SSCU After Major Surgery
Hypothesis: Patients with blue cerebrovascular reactivity (CVR) regional maps during a
hypercapnic CO2 challenge will be at greater risk of developing post-operative delirium (POD)
and stroke following major surgery. Blue CVR maps have also been recently documented with an
O2 challenge. The blue CVR maps will be shown to be predictive of POD and stroke and
ultimately represent a diagnostic test for patients at risk. These blue CVR maps will enable
neurologic risk stratification for patients undergoing major surgery. Background: Major
surgery is associated with a significant risk of postoperative morbidity and mortality. POD
is a dreaded complication with such anesthesia and surgery. The prevalence of delirium after
cardiac surgery has been reported to occur in up to 50% of patients. Using a definitive
diagnostic tool such as the Confusion Assessment Method - Intensive Care Unit (CAM-ICU and
CAM-S) results in the higher proportion reported. Delirium is a serious complication that
results in prolonged length of stay, increased health care costs, and higher mortality. As
much as $6.9 billion of Medicare hospital expenditures can be attributed to delirium. At such
a cost, better diagnosis and treatment is urgently needed. Pre-emptive diagnosis leading to
better management of delirium post-operatively is clearly one of the fundamental problems
confronting modern anesthesia and peri-operative medicine.
Specific Objectives: The investigators seek to address (a) the identity of patients who have
the greatest vulnerability to the surgery and (b) investigate the risks and test appropriate
risk mitigations. Understanding POD is of immense import to help control a hospital's
surgical and critical care costs. Patients with neurological consequences including POD often
represent a choke point for optimized critical care utilization. At the very least, improved
understanding and a diagnostic test to highlight patients at risk of POD would be most
welcome. Such an advance would permit rational strategies to limit the problem and allow
better designed therapeutic arcs for patients now known to be at risk. This is especially
important for patients undergoing complicated major surgery and is the focus of this pilot
project. Tighter control of ET respiratory gases may be indicated for both ET CO2 and ET O2
based on the results of this preliminary study.
Methods: Informed witnessed consent will be obtained from all participants. Patients will
have a Mini Mental State Exam (MMSE) prior to their MRI studies. A battery of neurocognitive
tests will be undertaken for each subject prior to surgery. This test battery will include
PHQ-9, GAD-7, Trails A and WAIS-IV Digit Span, Hopkins Verbal Learning Test Revised, Rey's
Complex Figure, DKEFS, F-A-S, CLOX I and II. This will take 45-60 minutes. Patients will have
CVR maps with blood oxygen level dependent (BOLD-MRI) pulse sequences done with standard
RespirAct (a computer-controlled gas blender) protocols in association with anatomic imaging
in a 3.0 Tesla magnet. The clinical care team and patient will be blinded as to the CVR
results. Patients will have standardized anesthesia and per usual approaches for their major
surgery and have standard POD assessment tools (CAM-ICU and CAM-S). Storage of anesthesia
hemodynamics will be to digital data acquisition systems for later collation. End-tidal CO2
will be targeted at patient baseline values +/- 2.5 mmHg during the surgical procedure and if
ventilated for any period post-operatively. Inspired O2 will be targeted to 0.3 - 0.6, based
on pulse oximetry of greater than 95% with adequate arterial oxygenation confirmed by ABG.
Standard fast-track protocols and admission to the surgical special care unit (SSCU) will be
undertaken to facilitate patient management. Any patient with obvious POD, post-op delirium
or stroke will be managed per usual protocols. Multiple CVR maps (650 studies) have been done
at University Health Network in Toronto. As well over 150 studies have been conducted at the
Health Sciences Centre at the University of Manitoba in the past 5 years.
Significance/Importance: This study has the potential to make an important contribution in
the understanding of POD for all surgical procedures and specifically a window into the
problem with major surgery. A positive study based on our hypothesis can fundamentally change
our understanding of cognitive dysfunction after surgery. Large follow-up multicentre trials
can be constructed based on initial findings from this pilot study if the study bears fruit.
At the least, further elucidation into POD for major surgery is expected with this study.
tighter control of end-tidal gases may be a consequence of the findings of this study.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03606941 -
Effect of Electroacupuncture on the Incidence of Postoperative Delirium in Elderly Patients Undergoing the Major Surgery
|
N/A | |
Recruiting |
NCT05990790 -
The Effect of Desflurane Versus Sevoflurane Versus Propofol on Postoperative Delirium
|
Phase 4 | |
Completed |
NCT03950440 -
Assessing the Incidence of Postoperative Delirium Following Aortic Valve Replacement
|
||
Terminated |
NCT03337282 -
Incidence and Characteristics of Postoperative Cognitive Dysfunction in Elderly Quebec Francophone Patients
|
||
Completed |
NCT02585128 -
Predictors of Postoperative Delirium After Transcatheter Aortic Valve Implantation
|
N/A | |
Recruiting |
NCT02227225 -
Factors Affecting the Incidence of Postoperative Delirium in Frail Elderly
|
N/A | |
Recruiting |
NCT01934049 -
Postoperative Recovery in Elderly Patients Undergoing Hip Hemi-arthroplasty
|
Phase 4 | |
Terminated |
NCT00455143 -
Cognitive Protection - Dexmedetomidine and Cognitive Reserve
|
Phase 4 | |
Recruiting |
NCT05010148 -
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
|
Phase 3 | |
Completed |
NCT06178835 -
EPO for Postop Delirium in Elderly Patients
|
Phase 4 | |
Recruiting |
NCT05992506 -
Electroencephalographic Biomarker to Predict Postoperative Delirium
|
||
Recruiting |
NCT03839784 -
Building a Platform for Precision Anesthesia in the Geriatric Surgical Patient
|
||
Completed |
NCT04154176 -
Validation of the Greek Version of the Confusion Assessment Method Diagnostic Algorithm (CAM) and the Nursing Delirium Screening Scale (Nu-DESC) and Their Inter-rater Reliablity
|
||
Not yet recruiting |
NCT06375265 -
Digital Sleep Optimization for Brain Health Outcomes in Older Surgical Patients
|
N/A | |
Recruiting |
NCT05572307 -
Peripheral Blood Single Cell Sequencing Analysis of POD and CPSP in Elderly Patients After Total Knee Arthroplasty
|
||
Active, not recruiting |
NCT03629262 -
Dexmedetomidine Supplemented Intravenous Analgesia in Elderly After Orthopedic Surgery
|
Phase 4 | |
Not yet recruiting |
NCT05537155 -
Buccal Acupuncture for Delirium Treatment in Older Patients Recovering From Orthopedic Surgery
|
N/A | |
Completed |
NCT01964274 -
Relevance of the Peripheral Cholinesterase-activity on Neurocognitive Dysfunctions in Surgical Patients
|
||
Completed |
NCT01599689 -
Pilot and Feasibility Study of a Mirrors Intervention for Reducing Delirium in Older Cardiac Surgical Patients
|
N/A | |
Active, not recruiting |
NCT03291626 -
Postoperative Delirium: EEG Markers of Sleep and Wakefulness
|